Held that the research and development expenses were incurred for future projects, the allocation of the said expenses incurred at head office level should not be apportioned to other units/undertaking unless the said expenditure relates to such an undertaking. (AY. 2009 10)
Macleods Pharmaceuticals Ltd. v. Dy. CIT (2022) 217 TTJ 763/ 214 DTR 105 (Mum)(Trib)
S. 35 : Scientific research expenditure-Allocation of expenses-Research and development expenses on future products-Allocation of expenses is not justified. [S.80IA, 80 IB, 80IC]